No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Adult
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Anti-Arrhythmia Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Balloon Valvuloplasty*
-
Calcinosis / diagnosis
-
Calcinosis / etiology
-
Calcinosis / physiopathology
-
Calcinosis / therapy*
-
Combined Modality Therapy
-
Cyanosis / diagnosis
-
Cyanosis / etiology
-
Cyanosis / physiopathology
-
Cyanosis / therapy*
-
Echocardiography, Doppler, Color
-
Exercise Test
-
Heart Defects, Congenital / complications*
-
Heart Defects, Congenital / diagnosis
-
Heart Defects, Congenital / physiopathology
-
Hemodynamics
-
Humans
-
Male
-
Pulmonary Circulation
-
Pulmonary Subvalvular Stenosis / etiology
-
Pulmonary Subvalvular Stenosis / therapy
-
Pulmonary Valve Stenosis / diagnosis
-
Pulmonary Valve Stenosis / etiology
-
Pulmonary Valve Stenosis / physiopathology
-
Pulmonary Valve Stenosis / therapy*
-
Radiography, Interventional
-
Severity of Illness Index
-
Time Factors
-
Treatment Outcome
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Anti-Arrhythmia Agents
-
Anticoagulants